Senti Biosciences Holdings, Inc. (SNTI) Form SCHEDULE 13D/A — Nov 18, 2026
New Enterprise Associates (NEA) filed Amendment No. 4 to its Schedule 13D on Senti Biosciences Holdings, reporting beneficial ownership of 8,775,115 shares, or 9.7% of the common stock. The filing states ownership decreased by more than 1% solely due to an increase in the number of shares outstanding, not an active sale. The 9.7% stake comprises 3,775,615 shares held of record plus a right to acquire up to 4,999,500 warrant shares, calculated against 90,705,763 outstanding shares (85,706,263 reported outstanding per Senti's Form 10-Q plus warrant shares).
Key figures
- Shares Owned
- 8775115
- Shares Outstanding
- 90705763
- Percent Owned
- 9.7%
- Record Shares
- 3775615
- Warrant Shares
- 4999500
- Outstanding Shares Per10 Q
- 85706263
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.